The Government Work Report 2018 points out the direction of development for the pharmaceutical industry
2019/4/25 11:58:39
On the morning of March 5, the first session of the 13th National People's Congress opened in the Great Hall of the People. Premier Li Keqiang made a number of suggestions on the work of the government in 2018, including several topics related to the implementation of the healthy China strategy, the promotion of "Internet +", the enhancement of technological innovation, the promotion of consumption upgrading, and the reform of the drug regulatory system.
I. Review of Work in the Past Five Years
Basic medical insurance covers 1.35 billion people: social endowment insurance covers more than 900 million people, and basic medical insurance covers 1.35 billion people, thus forming the largest social security network in the world. Life expectancy per capita reached 76.7 years.
The standard of basic medical insurance subsidy has been raised: the per capita financial subsidy standard of residents'basic medical insurance has been raised from 240 yuan to 450 yuan, the major disease insurance system has been basically established, more than 17 million people have benefited, the cost of hospitalization in different places has been settled directly, and the construction of graded medical treatment and Medical Union has been accelerated.
We have made breakthroughs in the reform of drug examination and approval by abolishing drug additions; carrying out the reform of medical treatment, medical insurance and medicine linkage; comprehensively pushing forward the comprehensive reform of public hospitals; abolishing the long-term policy of drug additions; making breakthroughs in the reform of the examination and approval system of drug and medical devices; reforming and perfecting the supervision of food and drugs; and strengthening the whole process control of risks.
II. Suggestions on the Work of the Government in 2018
1. Implementing the Healthy China Strategy
"To raise the level of basic medical insurance and major illness insurance, the per capita financial subsidy standard of basic medical insurance for residents will be increased by another 40 yuan, half of which will be used for major illness insurance. Expanding the scope of direct settlement of cross-provincial and off-site medical treatment, including primary hospitals, migrant workers, foreign employment entrepreneurs, etc. With the continuous improvement of the health insurance system, government investment has increased year by year, the level of health insurance security is steadily improving, and the scope of protection is also significantly expanded. This will be conducive to the steady expansion of the pharmaceutical market. Under the plan of 8 trillion yuan in the pharmaceutical health industry in 2020, the domestic pharmaceutical market is expected to continue to grow in the future.
Due to the uneven distribution and scarcity of medical resources, graded diagnosis and treatment and precise medical treatment will still be the key to promote medical reform in the future. The government's proposals of "strengthening the construction of general practitioners, promoting graded diagnosis and treatment" and "raising the per capita financial subsidy standard for basic public health services" will accelerate the improvement of medical services.
We should innovate the way of food and drug supervision, pay attention to improving the efficiency of supervision by using the Internet and big data, accelerate the realization of tracing and information traceability throughout the process, make the problem products nowhere to hide, illegal sellers can not escape the law, and let consumers buy at ease and eat safely. Innovation of food and drug regulation will solve the problem of product traceability in food and drug regulation, strengthen information security, and form an effective regulatory system.
2, promote the "Internet +" in the field of medical health.
"Bigger and stronger emerging industry clusters, implementing big data development actions, strengthening the research and application of the new generation of artificial intelligence, and promoting" Internet + "in many fields such as health care, pension, education, culture, sports and so on. "Artificial Intelligence" is emphasized for the first time in this report on the necessity of integration with traditional industries, "using new technologies, new formats and new modes to vigorously transform and upgrade traditional industries". Since 2017, the technology in various subdivisions of artificial intelligence is penetrating into traditional industries such as transportation, finance, security, medical treatment and so on. It has entered a critical moment from technology to industry landing. Nowadays, entrepreneurship innovation in the field of medicine and health has entered the deep industry chain. Big data and AI are bringing opportunities for change in the industry chain.
3. Strengthening the prevention and treatment of major diseases such as cancer
"Strengthening basic research and applied basic research, launching a number of major scientific and technological innovation projects, and building national laboratories with high standards. Enterprises should be encouraged to take the lead in implementing major scientific and technological projects, support scientific research institutes, universities and enterprises to integrate innovation and accelerate the transformation and application of innovation achievements. The state's investment in science and technology should be inclined to the field of people's livelihood, and tackle major diseases such as haze control, cancer prevention and control, so as to make science and technology better benefit the people.
Scientific and technological innovation plays a very obvious role in promoting the transformation and upgrading of the pharmaceutical industry. For example, in 2017, 174 new drugs of category 1 were declared for clinical application and production in China, which surpassed the number of previous years. At present, innovative drugs in China are mainly imitative and improved innovations, while basic science is still the short board that restricts the development of innovative drugs. With the gradual increase of national investment in basic science. It is expected that major breakthroughs will be made in the fields of cancer, liver diseases and other major diseases.
4. Promoting Consumption Upgrading
"Enhancing the basic role of consumption in economic development. Promote the upgrading of consumption and develop a new mode of consumption. Support social forces to increase the supply of medical, pension, education, culture, sports and other services. Consumption is becoming a strong driving force to support China's economic growth. An important opportunity in the field of medicine and health is the upgrading of consumption. The high-end, personalized and diversified needs of consumers are far from being met. How can we upgrade products and industries so as to keep the upgraded needs behind? This is the opportunity and challenge faced by enterprises.
5. Deeply Promoting Supply-side Structural Reform
"We will continue to focus on the real economy, continue to do a good job of reducing taxes and fees, simplify the administration, optimize the business environment, further stimulate the vitality of market players and improve the quality of economic development." In the field of medicine and health, whether it is the consistency evaluation of generic drugs or the implementation of priority examination and approval in recent years, in general, it is to eliminate backward production capacity, support advanced targets and promote the upgrading of industrial structure.
I. Review of Work in the Past Five Years
Basic medical insurance covers 1.35 billion people: social endowment insurance covers more than 900 million people, and basic medical insurance covers 1.35 billion people, thus forming the largest social security network in the world. Life expectancy per capita reached 76.7 years.
The standard of basic medical insurance subsidy has been raised: the per capita financial subsidy standard of residents'basic medical insurance has been raised from 240 yuan to 450 yuan, the major disease insurance system has been basically established, more than 17 million people have benefited, the cost of hospitalization in different places has been settled directly, and the construction of graded medical treatment and Medical Union has been accelerated.
We have made breakthroughs in the reform of drug examination and approval by abolishing drug additions; carrying out the reform of medical treatment, medical insurance and medicine linkage; comprehensively pushing forward the comprehensive reform of public hospitals; abolishing the long-term policy of drug additions; making breakthroughs in the reform of the examination and approval system of drug and medical devices; reforming and perfecting the supervision of food and drugs; and strengthening the whole process control of risks.
II. Suggestions on the Work of the Government in 2018
1. Implementing the Healthy China Strategy
"To raise the level of basic medical insurance and major illness insurance, the per capita financial subsidy standard of basic medical insurance for residents will be increased by another 40 yuan, half of which will be used for major illness insurance. Expanding the scope of direct settlement of cross-provincial and off-site medical treatment, including primary hospitals, migrant workers, foreign employment entrepreneurs, etc. With the continuous improvement of the health insurance system, government investment has increased year by year, the level of health insurance security is steadily improving, and the scope of protection is also significantly expanded. This will be conducive to the steady expansion of the pharmaceutical market. Under the plan of 8 trillion yuan in the pharmaceutical health industry in 2020, the domestic pharmaceutical market is expected to continue to grow in the future.
Due to the uneven distribution and scarcity of medical resources, graded diagnosis and treatment and precise medical treatment will still be the key to promote medical reform in the future. The government's proposals of "strengthening the construction of general practitioners, promoting graded diagnosis and treatment" and "raising the per capita financial subsidy standard for basic public health services" will accelerate the improvement of medical services.
We should innovate the way of food and drug supervision, pay attention to improving the efficiency of supervision by using the Internet and big data, accelerate the realization of tracing and information traceability throughout the process, make the problem products nowhere to hide, illegal sellers can not escape the law, and let consumers buy at ease and eat safely. Innovation of food and drug regulation will solve the problem of product traceability in food and drug regulation, strengthen information security, and form an effective regulatory system.
2, promote the "Internet +" in the field of medical health.
"Bigger and stronger emerging industry clusters, implementing big data development actions, strengthening the research and application of the new generation of artificial intelligence, and promoting" Internet + "in many fields such as health care, pension, education, culture, sports and so on. "Artificial Intelligence" is emphasized for the first time in this report on the necessity of integration with traditional industries, "using new technologies, new formats and new modes to vigorously transform and upgrade traditional industries". Since 2017, the technology in various subdivisions of artificial intelligence is penetrating into traditional industries such as transportation, finance, security, medical treatment and so on. It has entered a critical moment from technology to industry landing. Nowadays, entrepreneurship innovation in the field of medicine and health has entered the deep industry chain. Big data and AI are bringing opportunities for change in the industry chain.
3. Strengthening the prevention and treatment of major diseases such as cancer
"Strengthening basic research and applied basic research, launching a number of major scientific and technological innovation projects, and building national laboratories with high standards. Enterprises should be encouraged to take the lead in implementing major scientific and technological projects, support scientific research institutes, universities and enterprises to integrate innovation and accelerate the transformation and application of innovation achievements. The state's investment in science and technology should be inclined to the field of people's livelihood, and tackle major diseases such as haze control, cancer prevention and control, so as to make science and technology better benefit the people.
Scientific and technological innovation plays a very obvious role in promoting the transformation and upgrading of the pharmaceutical industry. For example, in 2017, 174 new drugs of category 1 were declared for clinical application and production in China, which surpassed the number of previous years. At present, innovative drugs in China are mainly imitative and improved innovations, while basic science is still the short board that restricts the development of innovative drugs. With the gradual increase of national investment in basic science. It is expected that major breakthroughs will be made in the fields of cancer, liver diseases and other major diseases.
4. Promoting Consumption Upgrading
"Enhancing the basic role of consumption in economic development. Promote the upgrading of consumption and develop a new mode of consumption. Support social forces to increase the supply of medical, pension, education, culture, sports and other services. Consumption is becoming a strong driving force to support China's economic growth. An important opportunity in the field of medicine and health is the upgrading of consumption. The high-end, personalized and diversified needs of consumers are far from being met. How can we upgrade products and industries so as to keep the upgraded needs behind? This is the opportunity and challenge faced by enterprises.
5. Deeply Promoting Supply-side Structural Reform
"We will continue to focus on the real economy, continue to do a good job of reducing taxes and fees, simplify the administration, optimize the business environment, further stimulate the vitality of market players and improve the quality of economic development." In the field of medicine and health, whether it is the consistency evaluation of generic drugs or the implementation of priority examination and approval in recent years, in general, it is to eliminate backward production capacity, support advanced targets and promote the upgrading of industrial structure.